Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

Eli Lilly & Co. is adding Alzheimer’s disease resources to the online platform it launched a year ago to sell obesity, ...

Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. | Eli Lilly is expanding its menu of ...

For individuals with dominantly inherited Alzheimer disease, long-term treatment with gantenerumab may delay clinical decline ...

Panelists discuss how health care institutions are leveraging strategic referral networks and telemedicine technologies to bridge geographical barriers, connect rural patients with specialized ...

Zunveyl (benzgalantamine) is now available for the treatment of mild to moderate dementia of the Alzheimer type in adults.

Panelists discuss how overcoming barriers to effective Alzheimer disease cognitive screening requires addressing multiple challenges including time constraints in clinical settings, inadequate ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in people with a genetic predisposition to the devastating condition.

Ekaterina Vasileva-Bagler/Getty Images Scientists in Brazil recently conducted a review to see how the probiotic kefir affects Alzheimer’s disease. Alzheimer’s disease is the most common form ...

Why are researchers still fumbling in the quest to cure what is arguably one of the most important diseases confronting humankind — Alzheimer’s disease? Despite decades of research ...

Now, researchers from Mass General Brigham have developed an innovative at-home smell test that could harness this knowledge to detect Alzheimer’s disease years before traditional symptoms emerge.

In China, a 19-year-old has been diagnosed with Alzheimer's disease, marking him as the world's youngest patient. Despite no gene mutation, other illness, or trauma explaining his condition ...